Publication Details

Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm
Denosumab (Xgeva ®, Prolia ®) [Polish]

Denosumab (Xgeva ®, Prolia ®) [Polish] (July 2017)

Denosumab is a targeted therapy used to treat secondary bone cancer. It is also given to people with certain cancers (breast cancer, prostate cancer) to strengthen their bones. This factsheet describes what denosumab is, how it works, how it is given, and the possible side effects.

Author(s)
Macmillan Cancer Support
Place of publication
London
Date of publication
July 2017
Pages
7pp
Format
Factsheet
Language
Polish
Download this resource
Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm